- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Construction output in Eastern Europe is expected to contract by 2% in 2023, as the headwinds that arose last year will continue to weigh on the industry and firms will struggle to sustain high levels of activity, according to GlobalData, a leading data and analytics company. Stronger-than-expected data from Q3 and Q4 2022 caused annual […]
Low carbon hydrogen to play defining role in energy transition, says GlobalData
The hydrogen market has progressed rapidly in recent years due to its growing application in industries like the transport, industrial, energy, aerospace, defence, and construction sectors. Against this backdrop, low carbon hydrogen is gaining traction as a critical component to achieve energy transition and long-term decarbonization goals, says GlobalData a leading data and analytics company. […]
Telecoms Scope 3 emissions reporting and management to become automated and proactive, says GlobalData
As environmental concerns grow, companies are under increasing pressure to report and reduce their greenhouse gas emissions. In particular, telecoms service providers face the challenge of measuring and reporting Scope 3 emissions, which account for the majority of their greenhouse gas (GHG) emissions. Against this backdrop, Scope 3 GHG reporting along supply chains can be […]
Digital transformation revolutionizing patient care, says GlobalData
The healthcare industry has transformed beyond conventional tools, embracing innovative technologies to enhance patient safety and care. With the seamless integration of technologies like AI, genomics, and robotics, patients can receive precise diagnoses and treatment, paving the way for a secure medical environment, says GlobalData, a leading data and analytics company. Kiran Raj, Practice Head […]
GlobalData forecasts oncology drug sales to generate $2.2 trillion between 2023 and 2029
In the race to combat cancer, the field of oncology has experienced strong growth in recent years. With forecasts pointing towards a continued upward trend, it is no surprise that the oncology market has emerged as the largest therapy area by sales, poised to generate $2.2 trillion in sales between 2023 and 2029. This significant […]
Lack of innovation means checkpoint inhibitor trials continue to focus primarily on PD-1/L1, says GlobalData
Over 95% of the ongoing Phase III trials in the US featuring an immune checkpoint modulator involve either a PD-1 or PD-L1-targeting drug. Given the proven efficacy of these targets this is not necessarily surprising. However, for patients unable to tolerate, or refractory to these drugs, this lack of innovation is disappointing, says GlobalData, a […]
GlobalData stresses need for patient education with injectable levodopa infusions for Parkinson’s disease treatment
Safety data on AbbVie’s ABBV-951 (foslevodopa/foscarbidopa) and NeuroDerm’s ND0612 (levodopa/carbidopa) for the treatment of Parkinson’s disease (PD) were showcased at the American Academy of Neurology (AAN) 2023 Annual Meeting. Should they receive FDA approval, these innovative levodopa delivery systems could offer an improved route of administration and will create additional options to control various motor […]
Astellas acquisition of Iveric Bio to boost ophthalmology portfolio, expected to achieve leadership position in geographic atrophy, says GlobalData
Following the news that Japan-based Astellas Pharma entered into a definitive agreement to acquire US-based biopharmaceutical company Iveric Bio for $5.9 billion to create a world class ophthalmology entity; Prashant Khadayate, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Astellas mentions blindness and regeneration as one of the five focus […]
India cumulative defense expenditure to reach $445.7 billion during 2024-28, forecasts GlobalData
India is presently the second-highest military spender after China in the Asia-Pacific region with a total defense budget of $74 billion in 2023. The cumulative defense spending of the country is projected to touch $445.7 billion from 2024-28, out of which the acquisition budget share is estimated to be approximately 28%, amounting to $123.2 billion, […]
UBS, Rothschild & Co top M&A financial advisers in automotive sector in Q1 2023, reveals GlobalData
UBS and Rothschild & Co were the top mergers and acquisitions (M&A) financial advisers in the automotive sector during the first quarter (Q1) of 2023 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that […]
White & Case, CMS top M&A legal advisers by value and volume in automotive sector in Q1 2023, reveals GlobalData
White & Case and CMS were the top mergers and acquisitions (M&A) legal advisers in the automotive sector during the first quarter (Q1) of 2023 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that […]
Credit and charge card payments in Australia to grow by 9.1% in 2023, forecasts GlobalData
The Australian credit and charge card market is set to grow by 9.1% in 2023, supported by rising consumer spending, forecasts GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that credit and charge card payments by value in Australia registered a strong growth of 17.0% in 2022. This was driven by […]
As Cytokinetics ALS drug fails Phase III trial, attention turns to cardiomyopathy candidate aficamten, says GlobalData
Cytokinetics, a San Francisco-based biotechnology company, is set to wind down the Phase III trial of its amyotrophic lateral sclerosis (ALS) pipeline drug, reldesemtiv, as there is no evidence of an effect compared to placebo on primary or secondary endpoints. This comes after the pharma company announced the FDA had rejected its heart failure drug, […]
India to lead midstream oil and gas project starts in Asia, with 129 projects planned during 2023-2027, forecasts GlobalData
India is likely to witness the start of operations of 129 midstream oil and gas projects from 2023 to 2027, accounting for 32% of the total upcoming midstream project starts in Asia by 2027, says GlobalData, a leading data, and analytics company. GlobalData’s latest report, “Oil and Gas Midstream New Build and Expansion Projects Analysis […]
Mobile service revenue in India to increase at 2.9% CAGR over 2022-2027, forecasts GlobalData
The total mobile services revenue in India is poised to increase at a compounded annual growth rate (CAGR) of 2.9% from $26.3 billion in 2022 to $30.3 billion in 2027, driven by the robust growth in mobile data services segment, forecasts GlobalData, a leading data and analytics company. GlobalData’s India Mobile Broadband Forecast (Q1 2023) […]
King’s Coronation to be celebrated by relaxing not retailing, says GlobalData survey
The King’s Coronation is an upcoming event that is anticipated to attract the attention of millions of people across the UK. However, retailers may not reap significant benefits from this occasion as consumers are more likely to use it as a time to rest and relax than to shop, according to a recent consumer survey* […]
Global top 25 technology companies gain over $2.4 trillion in Q1 2023 despite challenges, reveals GlobalData
Nvidia, Meta, Salesforce and AMD gain more than 50% in market cap in Q1 2023 FAAMG stocks continue to dominate the top 25 global tech stocks’ valuation The technology sector continues to be a driving force behind the global economic growth. Despite the ongoing challenges posed by geopolitical issues and interest rate hikes, the global […]
VC funding in China startups sees 48.2% drop to $9.5 billion in Q1 2023, reveals GlobalData
China-based startups had to navigate through a challenging regulatory environment and volatile market conditions during the first quarter (Q1) of 2023. As a result, they raised $9.5 billion in venture capital (VC) funding during the quarter, marking a 48.2% year-on-year (YoY) decline in deal value from Q1 2022, reveals GlobalData, a leading data and analytics […]
Venture capital investment in India down by 74% YoY to $2.4 billion in Q1 2023, reveals GlobalData
Venture capital (VC) funding activity in India seems to be still reeling from the funding drought that began in 2022. Despite significant entrepreneurial activity, the disclosed funding value of VC deals in the country suffered a massive year-on-year (YoY) 74% drop to $2.4 billion during the first quarter (Q1) of 2023, reveals GlobalData, a leading […]
GlobalData revises global growth projection for 2023 upward
As the world is gradually recovering from the impact of the COVID-19 pandemic and the Russia-Ukraine war, central banks worldwide are taking measures to reduce inflation by tightening their monetary policies. Along with this, the reopening and rebound of the Chinese economy is expected to resolve supply chain issues. Against this backdrop, GlobalData, a leading […]